Castle Biosciences News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.11.24	Castle Biosciences to Present at the Piper Sandler 36th Annual Healthcare Conference (Businesswire)
19.11.24	Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fourth Consecutive Year (Businesswire)
08.11.24	Castle Biosciences to Present New Data Highlighting the Clinical Performance of DecisionDx®-Melanoma and MyPath® Melanoma at the American Society of Dermatopathology 61st Annual Meeting (Businesswire)
07.11.24	Castle Biosciences Surpasses 25,000 Test Reports Delivered for its TissueCypher® Barrett’s Esophagus Test (Businesswire)
06.11.24	Use of Castle Biosciences’ DecisionDx®-Melanoma Test Significantly Reduces Unnecessary SLNB Procedures, Latest Findings from Prospective, Multicenter DECIDE Study Presented at Dermato-Onco2024 (Businesswire)
03.11.24	Ausblick: Castle Biosciences mit Zahlen zum abgelaufenen Quartal (finanzen.net)
28.10.24	Castle Biosciences to Participate in Upcoming Investor Conferences (Businesswire)
20.10.24	Erste Schätzungen: Castle Biosciences verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net)
16.10.24	Recent Publications Affirm the Value of Gene Expression Profile Testing in Guiding a Definitive Diagnosis and Clinical Decision-Making in Melanocytic Lesions of Uncertain Malignant Potential (Businesswire)
14.10.24	Castle Biosciences to Release Third Quarter 2024 Financial Results and Host Conference Call on Monday, Nov. 4, 2024 (Businesswire)
11.10.24	Castle Biosciences to Support the 71st Annual Montagna Symposium on the Biology of the Skin (Businesswire)
02.10.24	Castle Biosciences Hosts Groundbreaking Ceremony at Site of New Corporate Headquarters in Friendswood, Texas (Businesswire)
18.09.24	SLNO Skyrockets 800%, BWAY Blasts Past 400% - Were You On Board? (RTTNews)
16.09.24	Castle Biosciences’ Chief Operating Officer Kristen Oelschlager Named Arizona Bioscience Leader of the Year (Businesswire)
11.09.24	DecisionDx®-Melanoma Can Identify Melanoma Patients with Low Risk of Sentinel Lymph Node Positivity Who May Safely Forego Biopsy Surgery, New Independent Study Affirms (Businesswire)
05.09.24	Study Confirms the Ability of Castle Biosciences' DecisionDx®-SCC Test to Predict Likelihood of Benefit from Adjuvant Radiation Therapy in Patients with High-Risk Cutaneous Squamous Cell Carcinoma (Businesswire)
28.08.24	Castle Biosciences to Participate in Upcoming Investor Conferences (Businesswire)
04.08.24	Ausblick: Castle Biosciences verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net)
30.07.24	Castle Biosciences to Present at the Canaccord Genuity 44th Annual Growth Conference (Businesswire)
22.07.24	Castle Biosciences and Skin Cancer Survivor Teddi Mellencamp Arroyave Launch Campaign to Increase Awareness of Melanoma (Businesswire)
21.07.24	Erste Schätzungen: Castle Biosciences informiert über die jüngsten Quartalsergebnisse (finanzen.net)
15.07.24	Castle Biosciences to Release Second Quarter 2024 Financial Results and Host Conference Call on Monday, Aug. 5, 2024 (Businesswire)
11.07.24	Castle Biosciences Honored with Top Workplaces Awards (Businesswire)
20.06.24	Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Businesswire)
14.06.24	Castle Biosciences’ Founder, President and CEO Derek Maetzold Named an EY Entrepreneur Of The Year® 2024 Gulf South Award Winner (Businesswire)
15.05.24	Castle Biosciences to Present at the Leerink Partners Healthcare Crossroads Conference (Businesswire)
10.05.24	Castle Biosciences’ IDgenetix® Test Receives 2024 MedTech Breakthrough Award for "Best Overall Mental Health Solution” (Businesswire)
01.05.24	Ausblick: Castle Biosciences legt Quartalsergebnis vor (finanzen.net)
30.04.24	Castle Biosciences Kicks off Skin Cancer Awareness Month with a Ribbon Cutting to Celebrate the City of Friendswood’s Designation as a Sun Safe Leadership Model City by IMPACT Melanoma (Businesswire)
17.04.24	Erste Schätzungen: Castle Biosciences legt Quartalsergebnis vor (finanzen.net)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Castle Biosciences Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten